Decrease dose if: Experiencing consistent side effects (headaches, fatigue, GI disturbance), achieving satisfactory results at current dose with no need for escalation, or cost considerations favor using minimum effective dose
Morton JI, Ilomki J, Wood SJ, Bell JS, Shaw JE, Magliano DJ (2022) One-year readmission and mortality following ischaemic stroke by diabetes status, sex, and socioeconomic disadvantage: an analysis of 27,802 strokes from 2012 to 2017
10.1210/jc.2006-2846
The average age of patients in the sample was 60.9 years
NCT05872620
GlyHisLysCu(II) Peptide Sequence : GlyHisLys(Cu) Chemical Formula : CHNOCu (GHKCu complex) Molecular Weight : 401.91 g/mol CAS Number : 49557-75-7 Purity : Typically supplied at 99% purity as determined by HPLC